Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021
16 août 2021 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021
12 juil. 2021 08h15 HE
|
Nemaura Medical, Inc
Loughborough, England, July 12, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions
30 juin 2021 09h15 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Reports Results and Provides Business Update for the Fiscal Year Ended March 31, 2021
30 juin 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, June 30, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible...
Nemaura Medical to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
01 juin 2021 08h05 HE
|
Nemaura Medical, Inc
Loughborough, England, June 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Neumaura Medical, Inc. to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
26 mai 2021 08h05 HE
|
Nemaura Medical, Inc
Loughborough, England, May 26, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany
06 mai 2021 08h00 HE
|
Nemaura Medical, Inc
Loughborough, England, May 06, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
05 mai 2021 08h00 HE
|
Nemaura Medical, Inc
Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE Loughborough, England, May 05, 2021 (GLOBE...
Nemaura Medical to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 14, 2021
04 mai 2021 16h10 HE
|
Nemaura Medical, Inc
Loughborough, England, May 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call
29 avr. 2021 08h04 HE
|
Nemaura Medical, Inc
Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...